Daily non-political popular news in brief.
Study holds promise for new way to fight AIDS
11-01-2006 · EurekAlert!For years researchers have been trying to understand how a few HIV-infected patients naturally defeat a virus that otherwise overwhelms the immune system. New information about the structure of a key enzyme represents an early step toward the design of a new class of drugs that could afford to all the same natural protection enjoyed by few.
Read more »
Keywords: study, holds, promise, way, fight, aids, hold, aid
« Previous | Next »
Similar news on "Study holds promise for new way to fight AIDS":
- Turmeric prevents experimental rheumatoid arthritis, bone loss, University of Arizona study shows
10-30-2006 · EurekAlert!
Turmeric, a spice long used in traditional Asian medicine, may hold promise for the prevention of both rheumatoid arthritis and osteoporosis, according to a recently completed study at the University of Arizona College of Medicine. This work paves the way for the preclinical and clinical trials needed before turmeric supplements can be recommended for medicinal use in preventing or suppressing rheumatoid arthritis.
Similar news · Read more »
- Safety of new microbicide for HIV prevention to be tested in young women in US trial
07-09-2007 · EurekAlert!
In an effort to help stem the tide of the HIV/AIDS epidemic, particularly in women, researchers have launched a clinical safety trial of a topical vaginal microbicide with a unique molecular structure that holds promise for preventing the sexual transmission of HIV. The Microbicide Trials Network is leading the NIH-funded study in which VivaGel is being tested for the first time in sexually active young women to determine its safety, acceptability and ease of use.
Similar news · Read more »
- Knocking out survival protein could aid leukemia treatment
04-20-2007 · EurekAlert!
An effective way to fight leukemia might be to knock out a specific protein that protects cancer cells from dying, a new study shows. The findings suggest that a drug that can block this "survival protein" might on its own be an effective therapy.
Similar news · Read more »
- Discovery of an HIV inhibitor in human blood points to new drug class
04-19-2007 · EurekAlert!
A new study has pinpointed a natural ingredient of human blood that effectively blocks HIV-1, the virus predominantly responsible for human AIDS, from infecting immune cells and multiplying. The virus blocker might play a role in the progression of HIV to full-blown AIDS and -- because it works in a different way than existing antiretroviral inhibitors -- could lead to the development of another class of drugs in the fight against the pandemic disease.
Similar news · Read more »
- Proteochemometrics achieves better retardants for HIV/Aids
03-14-2007 · EurekAlert!
A new method for analysis of retroviral proteins gives new opportunities to the development of novel retardants for HIV/Aids. The study, which was published in the March issue of PLoS Computational Biology, shows how to in a very exact way analyze the interaction of drug targets with small molecules.
Similar news · Read more »
- Polymers hold promise for safer gene delivery
09-07-2007 · Massachusetts Institute of Technology (MIT)
In work that could lead to safe and effective techniques for gene therapy, MIT scientists have found a way to fine-tune the ability of biodegradable polymers to deliver genes, which could be a safer technique than using viruses to carry genes.
Similar news · Read more »
- No more seizures? New drug holds promise for epilepsy patients
02-05-2007 · EurekAlert!
People with newly diagnosed epilepsy experienced few, if any, seizures while taking the drug levetiracetam as a single therapy, giving hope to epilepsy patients who don't respond to or can't tolerate existing treatments, according to a study published in the Feb. 6, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
Similar news · Read more »
- Study: Fountain of youth for your heart?
11-02-2007 · EurekAlert!
University of Alberta professor Jason Dyck's findings suggest that the protein responsible for transporting fat into the contractile cells of the heart may be a candidate for drug inhibition and that this drug could protect the heart from aging. This research holds great promise for human beings. Dyck hopes it will lead to the development of medications that inhibit the uptake of fatty acids into the heart and prevent and/or reverse the effects of aging on the heart muscle.
Similar news · Read more »
- Rhesus macaque genome may hold clues for human health and evolution
04-12-2007 · EurekAlert!
An international consortium of scientists has completed a draft sequence of the rhesus macaque genome, a species of non-human primate widely used for creating models of human diseases and infections. The study paves the way for researchers to watch disease progression at the genetic level in macaques, a close relative of humans. The findings, which appear April 13 in the journal Science, will let us learn how humans and other primates evolved into distinct species.
Similar news · Read more »
- Peptide vaccine fights off breast tumors with aid of bacteria-mimicking agents
02-01-2007 · EurekAlert!
With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice. The strategy, they say, holds promise for the future use of peptide vaccines in women who are at high risk for developing breast cancer.
Similar news · Read more »